搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Burkholderia xenovorans 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (bphD) CSB-YP342870BNV
CSB-EP342870BNV
CSB-BP342870BNV
CSB-MP342870BNV
CSB-EP342870BNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium DNA polymerase III subunit beta (dnaN) CSB-YP342871MLN
CSB-EP342871MLN
CSB-BP342871MLN
CSB-MP342871MLN
CSB-EP342871MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized deoxyribonuclease MG009 (MG009) CSB-YP342872MLN
CSB-EP342872MLN
CSB-BP342872MLN
CSB-MP342872MLN
CSB-EP342872MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Chaperone protein DnaJ (dnaJ) CSB-YP342873MLN
CSB-EP342873MLN
CSB-BP342873MLN
CSB-MP342873MLN
CSB-EP342873MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG027 (MG027) CSB-YP342874MLN
CSB-EP342874MLN
CSB-BP342874MLN
CSB-MP342874MLN
CSB-EP342874MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Histidine--tRNA ligase (hisS) CSB-YP342875MLN
CSB-EP342875MLN
CSB-BP342875MLN
CSB-MP342875MLN
CSB-EP342875MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Spermidine/putrescine transport system permease protein PotB homolog (potB), partial CSB-YP342876MLN1
CSB-EP342876MLN1
CSB-BP342876MLN1
CSB-MP342876MLN1
CSB-EP342876MLN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium SsrA-binding protein (smpB) CSB-YP342877MLN
CSB-EP342877MLN
CSB-BP342877MLN
CSB-MP342877MLN
CSB-EP342877MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized lipoprotein MG068 (MG068) CSB-YP342878MLN
CSB-EP342878MLN
CSB-BP342878MLN
CSB-MP342878MLN
CSB-EP342878MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG075 (MG075), partial CSB-YP342879MLN
CSB-EP342879MLN
CSB-BP342879MLN
CSB-MP342879MLN
CSB-EP342879MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Peptidyl-tRNA hydrolase (pth) CSB-YP342880MLN
CSB-EP342880MLN
CSB-BP342880MLN
CSB-MP342880MLN
CSB-EP342880MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP342881MLN
CSB-EP342881MLN
CSB-BP342881MLN
CSB-MP342881MLN
CSB-EP342881MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG116 (MG116) CSB-YP342882MLN
CSB-EP342882MLN
CSB-BP342882MLN
CSB-MP342882MLN
CSB-EP342882MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG123 (MG123), partial CSB-YP342883MLN1
CSB-EP342883MLN1
CSB-BP342883MLN1
CSB-MP342883MLN1
CSB-EP342883MLN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized HIT-like protein MG132 (MG132) CSB-YP342884MLN
CSB-EP342884MLN
CSB-BP342884MLN
CSB-MP342884MLN
CSB-EP342884MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Transcription elongation protein nusA (nusA), partial CSB-YP342885MLN
CSB-EP342885MLN
CSB-BP342885MLN
CSB-MP342885MLN
CSB-EP342885MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium 30S ribosomal protein S10 (rpsJ) CSB-YP342886MLN
CSB-EP342886MLN
CSB-BP342886MLN
CSB-MP342886MLN
CSB-EP342886MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium 50S ribosomal protein L16 (rplP) CSB-YP342887MLN
CSB-EP342887MLN
CSB-BP342887MLN
CSB-MP342887MLN
CSB-EP342887MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium 50S ribosomal protein L6 (rplF) CSB-YP342888MLN
CSB-EP342888MLN
CSB-BP342888MLN
CSB-MP342888MLN
CSB-EP342888MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium 50S ribosomal protein L36 (rpmJ) CSB-YP342889MLN
CSB-EP342889MLN
CSB-BP342889MLN
CSB-MP342889MLN
CSB-EP342889MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>